Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
PTEN Hamartoma Tumor Syndrome clinical trials
1 of 2 indexed PTEN Hamartoma Tumor Syndrome trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
PTEN Hamartoma Tumor Syndrome: 2 US clinical trials tracked, 1 recruiting.
PTEN Hamartoma Tumor Syndrome is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is John Carroll University, running 1 of these trials.
Enrollment posture brief
Registry condition pten-hamartoma-tumor-syndrome
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
PTEN Hamartoma Tumor Syndrome lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for PTEN Hamartoma Tumor Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
PTEN Hamartoma Tumor Syndrome is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Boston Children's Hospital
NCT02461446
Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients
John Carroll University
NCT05671107
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on PTEN Hamartoma Tumor Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on PTEN Hamartoma Tumor Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this PTEN Hamartoma Tumor Syndrome page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 PTEN Hamartoma Tumor Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- John Carroll University sponsors the most PTEN Hamartoma Tumor Syndrome trials on record, review their full trial history before evaluating a specific study. See John Carroll University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PTEN Hamartoma Tumor Syndrome condition card totals 2 registered trials; most-linked intervention NET; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.